NCT02883686

Randomized Controlled Trial of the Alma Peer Mentoring Program for Pregnant Women Experiencing Depression

Completed NA Last updated 6 May 2020

What this trial tests

NA trial testing Alma in Depression in 27 participants. Completed in 28 April 2020.

Timeline

6 February 2019

Primary endpoint
28 April 2020

28 April 2020

Quick facts

Lead sponsor	University of Colorado, Boulder
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	27
Start date	6 February 2019
Primary completion	28 April 2020
Estimated completion	28 April 2020
Sites	2 locations across United States

Drugs / interventions tested

• Alma

Conditions studied

• Depression — all drugs for Depression →
• Depression, Postpartum — all drugs for Depression, Postpartum →

Sponsor

University of Colorado, Boulder

Who can join

18 and older, female only, with Depression or Depression, Postpartum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Women have double the odds of getting depressed as men and commonly experience depression during the childbearing and early parenting years. Many new and expectant mothers who experience depression never receive help. Alma is a new program, collaboratively developed by a team of researchers, clinicians, and mothers who have personal experience with depression, to support women experiencing depression during pregnancy and the postpartum period. In the Alma program, mothers who themselves have experienced and recovered from depression during the perinatal period, are trained to provide peer mentoring to depressed new and expectant mothers. Peer mentors are trained by professionals who are experts in using skills to recover from depression. These skills are informed by an evidence-based framework called Behavioral Activation (BA). Peer mentors do not provide psychotherapy and are not licensed mental health providers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.